{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:49:52Z","timestamp":1786117792593,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.gene.2026.150295","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:36:43Z","timestamp":1782949003000},"page":"150295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reduced ATXN1 expression as an adverse prognostic indicator in Acute myeloid leukemia"],"prefix":"10.1016","volume":"1009","author":[{"given":"An-qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-liu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-yang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8564-8052","authenticated-orcid":false,"given":"Wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150295_b0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.2021011103","article-title":"Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy","volume":"138","author":"Itzykson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.gene.2026.150295_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10238-024-01536-4","article-title":"The clinical features and outcomes of elderly patients with acute myeloid leukemia: a real word research","volume":"25","author":"Han","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.gene.2026.150295_b0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2022.280801","article-title":"The clinical impact of the molecular landscape of acute myeloid leukemia","volume":"108","author":"Kayser","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.gene.2026.150295_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-021-00207-4","article-title":"Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns","volume":"10","author":"Guan","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.gene.2026.150295_b0025","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020009680","article-title":"CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome","volume":"139","author":"Taube","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.gene.2026.150295_b0030","first-page":"3533","article-title":"Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases","volume":"109","author":"Badar","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.gene.2026.150295_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12122921","article-title":"Acute Myeloid Leukemia with Normal Cytogenetics and NPM1-Mutation: Impact of Mutation Topography on Outcomes","volume":"12","author":"Zhao","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.gene.2026.150295_b0040","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/leu.2016.126","article-title":"RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features","volume":"30","author":"Gaidzik","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2026.150295_b0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"24","author":"Boultwood","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2026.150295_b0050","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2026.150295_b0055","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1182\/bloodadvances.2024013685","article-title":"Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy","volume":"8","author":"Hoff","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.gene.2026.150295_b0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150295_b0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ng.3808","article-title":"Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans","volume":"49","author":"Lu","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150295_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2022.11.017","article-title":"Decreasing mutant ATXN1 nuclear localization improves a spectrum of SCA1-like phenotypes and brain region transcriptomic profiles","volume":"111","author":"Handler","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.gene.2026.150295_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1280546","article-title":"Intranuclear inclusions of polyQ-expanded ATXN1 sequester RNA molecules","volume":"16","author":"Gkekas","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.gene.2026.150295_b0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ajhg.2024.03.015","article-title":"CAG repeat mosaicism is gene specific in spinocerebellar ataxias","volume":"111","author":"Kacher","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2026.150295_b0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/brain\/awad329","article-title":"Widespread alternative splicing dysregulation occurs presymptomatically in CAG expansion spinocerebellar ataxias","volume":"147","author":"Shorrock","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.gene.2026.150295_b0090","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/acn3.51618","article-title":"Epigenetic control of ataxin-1 in multiple sclerosis","volume":"9","author":"Ma","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.gene.2026.150295_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13041-020-00715-0","article-title":"The novel multiple sclerosis susceptibility gene ATXN1 regulates B cell receptor signaling in B-1a cells","volume":"14","author":"Ma","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.gene.2026.150295_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.2006.06388.x","article-title":"Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia","volume":"136","author":"Auer","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.gene.2026.150295_b0105","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.gene.2026.150295_b0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.gene.2026.150295_b0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.gene.2026.150295_b0120","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1038\/s41467-024-50618-0","article-title":"Community assessment of methods to deconvolve cellular composition from bulk gene expression","volume":"15","author":"White","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150295_b0125","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1007\/s12094-023-03168-8","article-title":"Aging-related genes related to the prognosis and the immune microenvironment of acute myeloid leukemia","volume":"25","author":"Gang","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.gene.2026.150295_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.gene.2026.150295_b0135","doi-asserted-by":"crossref","first-page":"23742","DOI":"10.1073\/pnas.2003798117","article-title":"Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis","volume":"117","author":"Didonna","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150295_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116132","article-title":"Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective","volume":"171","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.gene.2026.150295_b0145","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2026.150295_b0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1158\/2643-3230.BCD-23-0202","article-title":"Recent advances in Immune-based Therapies for Acute Myeloid Leukemia","volume":"5","author":"Restelli","year":"2024","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.gene.2026.150295_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004794","article-title":"TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis","volume":"10","author":"Brauneck","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.gene.2026.150295_b0160","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9988405","article-title":"CD86 is Associated with Immune Infiltration and Immunotherapy Signatures in AML and Promotes its Progression","volume":"2023","author":"Zhang","year":"2023","journal-title":"J. Oncol."},{"key":"10.1016\/j.gene.2026.150295_b0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/bloodadvances.2023010786","article-title":"The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia","volume":"8","author":"Cunningham","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.gene.2026.150295_b0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trecan.2020.04.011","volume":"6","author":"Wang","year":"2020","journal-title":"RNA Splicing and Cancer. Trends Cancer"},{"key":"10.1016\/j.gene.2026.150295_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.01.010","article-title":"Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia","volume":"35","author":"Wang","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926003057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926003057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:30:29Z","timestamp":1786026629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926003057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":35,"alternative-id":["S0378111926003057"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150295","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced ATXN1 expression as an adverse prognostic indicator in Acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150295"}}